APA (7th ed.) Citation

DJ, S., DH, L., JM, R., RM, C., DM, M., J, T., . . . P, H. (2011). gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. The New England journal of medicine, 364(22), 2119. https://doi.org/10.1056/NEJMoa1012863

Chicago Style (17th ed.) Citation

DJ, Schwartzentruber, et al. "Gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma." The New England Journal of Medicine 364, no. 22 (2011): 2119. https://doi.org/10.1056/NEJMoa1012863.

MLA (9th ed.) Citation

DJ, Schwartzentruber, et al. "Gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma." The New England Journal of Medicine, vol. 364, no. 22, 2011, p. 2119, https://doi.org/10.1056/NEJMoa1012863.